Abstract
The aim of this study was to formulate and systemically evaluate the in-vitro Metformin Hydrochloride (MTH) loaded guar gum microspheres. The formulations were prepared by solvent evaporation technique using non-halogenated solvents and evaluated for various micrometric parameters, in-vitro drug release and for model fitting kinetics. The results of micrometric, studies indicated that the microspheres had good flow property and drug entrapment efficiency was in the range of 32.40±2 (62%) to 71.16±3 (81%). The in-vitro drug release was found to be sustained for 24hr time period and obeyed zero order kinetic release. The optimized formulation was found to be stable as indicated by the stability studies wherein no significant changes with respect to physical appearance and drug content were observed at the end of three months. The optimized microspheres of MTH were found to be stable and showed desired sustained effect.
Keywords: Microsphere, Formulation, Model, Ptimization, Stability
Nanoscience & Nanotechnology-Asia
Title:Development and Characterization of Biodegradable Polymeric Microspheres of Metformin Hydrochloride
Volume: 2 Issue: 2
Author(s): Hema Chaudhary, Minakshi Ahlawat and Vikash Kumar
Affiliation:
Keywords: Microsphere, Formulation, Model, Ptimization, Stability
Abstract: The aim of this study was to formulate and systemically evaluate the in-vitro Metformin Hydrochloride (MTH) loaded guar gum microspheres. The formulations were prepared by solvent evaporation technique using non-halogenated solvents and evaluated for various micrometric parameters, in-vitro drug release and for model fitting kinetics. The results of micrometric, studies indicated that the microspheres had good flow property and drug entrapment efficiency was in the range of 32.40±2 (62%) to 71.16±3 (81%). The in-vitro drug release was found to be sustained for 24hr time period and obeyed zero order kinetic release. The optimized formulation was found to be stable as indicated by the stability studies wherein no significant changes with respect to physical appearance and drug content were observed at the end of three months. The optimized microspheres of MTH were found to be stable and showed desired sustained effect.
Export Options
About this article
Cite this article as:
Chaudhary Hema, Ahlawat Minakshi and Kumar Vikash, Development and Characterization of Biodegradable Polymeric Microspheres of Metformin Hydrochloride, Nanoscience & Nanotechnology-Asia 2012; 2 (2) . https://dx.doi.org/10.2174/2210681211202020190
DOI https://dx.doi.org/10.2174/2210681211202020190 |
Print ISSN 2210-6812 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6820 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies for Salt Reduction in Foods
Recent Patents on Food, Nutrition & Agriculture Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines
Current Molecular Pharmacology p53 Activation by Blocking Snail : A Novel Pharmacological Strategy for Cancer
Current Pharmaceutical Design Histone Deacetylase 2 in the Mouse Hippocampus: Attenuation of Age- Related Increase by Caloric Restriction
Current Alzheimer Research EDITORIAL [Hot Topic: Molecularly Targeted Treatments for Colorectal Cancer: Advances and Limitations (Guest Editor: Silvio Parodi)]
Current Cancer Drug Targets Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?
Current Medicinal Chemistry Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pharmacology of Topoisomerase I Inhibitors Irinotecan (CPT-11) and Topotecan
Current Cancer Drug Targets MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Molecular and Cellular Regulators of Cancer Angiogenesis
Current Cancer Drug Targets Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy Editorial (Thematic Issue: Gene Therapy for Gastrointestinal and Liver Cancers: Past Experience, Current Status and Future Perspectives)
Current Gene Therapy Nampt/Visfatin/PBEF: A Functionally Multi-faceted Protein with a Pivotal Role in Malignant Tumors
Current Pharmaceutical Design Pharmaceutical Strategies Enhancing Cell Penetration Efficiencies of Non-Viral Gene Delivery Systems
Current Gene Therapy Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art
Recent Patents on Drug Delivery & Formulation